Reactive oxygen species and endothelial function in diabetes

European Journal of Pharmacology

Volumn 636, Issue 1-3, 2010, Pages 8-17

  Fatehi Hassanabad, Zahra ^a   Chan, Catherine B ^a   Furman, Brian L ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Diabetes; Endothelial function; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; APOCYNIN; ASCORBIC ACID; CYTOCHROME P450; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; GROWTH FACTOR; IDEBENONE; LIPID; MAGNESIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NORPHENAZONE; PLACEBO; PROBUCOL; PROTEIN KINASE C; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; TEMPOL; XANTHINE OXIDASE; ZINC;

ALBUMINURIA; CELL FUNCTION; CLINICAL TRIAL; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG ACTIVITY; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME ACTIVATION; GLOMERULOSCLEROSIS; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; KIDNEY HYPERTROPHY; KIDNEY ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; DIABETES MELLITUS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 77952675536     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.048     Document Type: Review

References (193)

1. Abraham N.G., Pinto A., Levere R.D., Mullane K. Identification of heme oxygenase and cytochrome P-450 in the rabbit heart. J. Mol. Cell. Cardiol. 1987, 19:73-81.
2. Aikens J., Dix T.A. Perhydroxyl radical (HOO′) initiated lipid peroxidation: the role of fatty acid hydroperoxides. J. Bio. Chem. 1991, 266:15091-15098.
3. Akkus I., Kalak S., Vural H., Caglayan O., Menekse E., Can G., Durmuş B. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin. Chim. Acta. 1996, 244:221-227.
4. Althaus F.R., Kleczkowska H.E., Malanga M., Muntener C.R., Pleschke J.M., Ebner M., Auer B. A DNA break signal mechanism. Mol. Cell. Biochem. 1999, 193:5-11.
5. Anderson M.M., Heinecke J.W. Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes 2003, 52:2137-2143.
6. Antosiewicz J., Ziolkowski W., Kaczor J.J., Herman-Antosiewicz A. Tumor necrosis factor-alpha-induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool. Free Radic. Biol. Med. 2007, 43:265-270.
7. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
8. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
9. Belin de Chantemèle E.J., Vessières E., Guihot A.L., Toutain B., Maquignau M., Loufrani L., Henrion D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc. Res. 2009, 81:788-796.
10. Bharadwaj L.A., Prasad K. Mechanism of superoxide anion-induced modulation of vascular tone. Int. Angiology 2002, 11:23-29.
11. Bitar M.S., Wahid S., Mustafa S., Al-Saleh E., Dhaunsi G.S., Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur. J. Pharmacol. 2005, 511:53-64.
12. Browne D., Meeking D., Shaw K., Cummings M. Endothelial dysfunction and presymptomatic atherosclerosis in type 1 diabetes - pathogenesis and identification. Br. J. Diabetes Vasc. Dis. 2003, 3:27-34.
13. Bruder G., Jarasch E.D., Heid H.W. High concentrations of antibodies to xanthine oxidase in human and animal sera: molecular characterization. J. Clin. Invest. 1984, 74:783-794.
14. Burkart V., Wang Z.Q., Radons J., Heller B., Herceg Z., Stingl L., Wagner E.F., Kolb H. Mice lacking the poly (ADPribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med. 1999, 5:314-319.
15. Burnham M.P., Johnson I.T., Weston A.H. Impaired small-conductance Ca2+-activated K +channel-dependent EDHF responses in Type II diabetic ZDF rats. Br. J. Pharmacol. 2006, 148:434-441.
16. Bursell S.E., Clermont A.C., Aiello L.P., Aiello L.M., Schlossman D.K., Feener E.P., Laffel L., King G.L. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999, 22:1245-1251.
17. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68:26-36.
18. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium derived hyperpolarizing factors. Circ. Res. 1996, 78:415-423.
19. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001, 44:834-838.
20. Cheng J., Wu C.C., Gotlinger K.H., Zhang F., Narsimhaswamy D., Falck J.R., Schwartzman M.L. 20-HETE mediate endothelial dysfunction via IKK-dependent eNOS uncoupling. J. Pharmacol. Exp. Ther. 2010, 232:57-65.
21. Clark R.A., Valente A.J. Nuncear factor kappB activation by NADPH oxidases Mech. Ageing Dev. 2004, 125:799-810.
22. Collins-Underwood J.R., Zhao W., Sharpe J.G., Robbins M.E. NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells. Free Radic. Biol. Med. 2008, 45:929-938.
23. Cook J.P. The endothelium: a new target for therapy. Vasc. Med. 2000, 5:49-53.
24. Coppey L.J., Gellett J.S., Davidson E.P., Yorek M.A. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic. Res. 2003, 37:33-40.
25. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly (ADP) ribosylation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342:249-268.
26. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
27. Dhanasekaran A., Kotamraju S., Kalivendi S.V., Matsunaga T., Shang T., Keszler A., Joseph J., Kalyanaraman B. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J. Biol. Chem. 2004, 279:37575-37587.
28. Nathan D.M., Zinman B., Cleary P.A., Backlund J.Y., Genuth S., Miller R., Orchard T.J. Modern-day clinical course of type 1 diabetes mellitus after 30years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and ittsburgh epidemiology of diabetes complications experience (1983-2005). Arch. Intern. Med. 2009, 169:1307-1316. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.
29. 2- generation by mononuclear phagocytes in diabetes. J. Leukoc. Biol. 2007, 81:520-527.
30. Dixon L.J., Hughes S.M., Rooney K., Madden A., Devine A., Leahey W., Henry W., Johnston G.D., McVeigh G.E. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Am. J. Hypertion 2005, 18:839-843.
31. Doi K., Suzuki Y., Nakao A., Fujita T., Noiri E. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int. 2004, 65:1714-1723.
32. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
33. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 2003, 112:1049-1057.
34. Du X., Edelstein D., Obici S., Higham N., Zou M.H., Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J. Clin. Invest. 2006, 116:1071-1080.
35. Edgley A.J., Tare M., Evans R.G., Skordilis C., Parkington H.C. In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes. Am. J. Physiol. 2008, 295:R829-R839.
36. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 1997, 3:1089-1095.
37. El-Mesallamy H., Suwailem S., Hamdy N. Evaluation of C-reactive protein, endothelin-1, adhesion molecule(s), and lipids as inflammatory markers in type 2 diabetes mellitus patients. Mediat. Inflamm. 2007, 2007:73635-73642.
38. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., Cooper M.E., Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 2008, 205:2409-2417.
39. Endemann D.H., Schiffrin E.L. Endothelial dysfunction. J. Am. Soc. Nephrol. 2004, 15:1983-1992.
40. Esper R.J., Vilariño J.O., Machado R.A., Paragano A. Endothelial dysfunction in normal and abnormal glucose metabolism. Adv. Cardiol. 2008, 45:17-43.
41. Farvid M.S., Jalali M., Siassi F., Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005, 28:2458-2464.
42. Fenton H.J.H. Oxidation of tartaric acid in the presence of iron. J. Chem. Soc. 1894, 65:899-910.
43. Ferreira I.A., Mocking A.I., Feijge M.A., Gorter G., van Haeften T.W., Heemskerk J.W., Akkerman J.W. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 2006, 26:417-422.
44. Fisslthaler B., Popp R., Kiss L., Potente M., Harder D.R., Fleming I., Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999, 401:493-497.
45. Fitzgerald S.M., Kemp-Harper B.K., Parkington H.C., Head G.A., Evans R.G. Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor. Am. J. Physiol. 2007, 293:R707-R713.
46. Fleming I., Michaelis U.R., Bredenkotter D., Fisslthaler B., Dehghani F., Brandes R.P., Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is functionally significant source of reactive oxygen species in coronary arteries. Circ. Res. 2001, 88:44-51.
47. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
48. Fukao M., Hattori Y., Kanno M., Sakuma I., Kitabatake A. Alterations in endothelium-depenednt hyperpolarization and relaxation in mesenteric arteries from streptozotocine-induced diabetic rats. Br. J. Pharmacol. 1997, 121:1383-1391.
49. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
50. Gao L., Mann G.E. Vascular NADPH oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc. Res. 2009, 82:9-20.
51. db mice. Circulation 2007, 115:245-254.
52. Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., Marton A., Hoyt D.G., Murthy K.G., Salzman A.L., Southan G.J., Szabo C. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat. Med. 2001, 7:108-113.
53. Gauss K.A., Nelson-Overton L.K., Siemsen D.W., Gao Y., Deleo F.R., Quinn M.T. Role of NF-{kappa}B in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-{alpha}. J. Leukoc. Biol. 2007, 82:729-741.
54. Geiszt M. NADPH oxidases: new kids on the block. Cardiovas. Res. 2006, 71:289-299.
55. Gertzberg N., Neumann P., Rizzo V., Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am. J. Physiol. 2004, 286:L37-L48.
56. Graier W.F., Pusch K., Wascher T. Increased superoxide formation in endothelial cells during hyperglycemia. Diabetes Res. Clin. Prac. 1999, 45:153-160.
57. Green K., Brand M.D., Murphy M.P. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004, 53(Suppl. 1):S110-S118.
58. Griendling K.K. ATVB in focus: redox mechanisms in blood vessels. Arterios. Thromb. Vasc. Biol. 2005, 25:272-273.
59. Griendling K.K., Sorescu D., Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ. Res. 2000, 86:494-501.
60. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of NO. Nature 1986, 320:455-456.
61. Guzik T.J., West N.E.J., Black E., McDonald D., Ratnatunga C., Pillai R., Channon K.M. Vascular superoxide production by NADPH oxidase. Circ. Res. 2000, 86:e85-e90.
62. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59:1609-1623.
63. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 1997, 100:2153-2157.
64. Hattori Y., Kawasaki H., Abe K., Kanno M. SOD recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 1991, 261:H1086-H1094.
65. Hausse A.O., Aggoun Y., Bonnet D., Sidi D., Munnich A., Rötig A., Rustin P. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 2002, 87:346-349.
66. Higashi Y. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Exp. Opin. Pharmacother. 2009, 10:323-331.
67. Higashi Y., Jitsuiki D., Chayama K., Yoshizumi M. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent. Pat. Cardiovasc. Drug. Discov. 2006, 1:85-93.
68. Hille R., Nishino T. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 1995, 9:995-1003.
69. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 2001, 88:E14-E22.
70. Hirsch I.B., Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control?. J. Diabetes Complications 2005, 19:178-181.
71. Hoeldtke R.D., Bryner K.D., Corum L.L., Hobbs G.R., Van Dyke K. Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA. Metabolism 2009, 58:731-734.
72. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
73. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008, 359:1577-1589.
74. Hool L.C., Corry B. Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid. Redox. Signal. 2007, 9:409-435.
75. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A.-M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
76. Hu Q., Zheng G., Zweier J.L., Deshpande S., Irani K., Ziegelstein R.C. NADPH oxidase activation increases the sensitivity of intracellular Ca2+ stores to inositol 1, 4, 5-trisphosphate in human endothelial cells. J. Biol. Chem. 2000, 275:15749-15757.
77. Inkster M.E., Cotter M.A., Cameron N.E. Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats. Free Radic. Res. 2002, 36:1091-1099.
78. Inkster M.E., Cotter M.A., Cameron N.E. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur. J. Pharmacol. 2007, 561:63-71.
79. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in caltures vascular cells. Diabetes 2000, 49:1939-1945.
80. Jagtap P., Szabo C. Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug. Discov. 2005, 4:421-440.
81. Jarasch E.D., Grund C., Bruder G., Heid H.W., Keenan T.W., Franke W.W. Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell 1981, 25:67-82.
82. Jernigan N.L., Resta T.C., Walker B.R. Contribution of oxygen radicals to altered NO-dependent pulmonary vasodilation in acute and chronic hypoxia. Am. J. Physiol. 2004, 286:L947-L955.
83. Kajiya M., Hirota M., Inai Y., Kiyooka T., Morimoto T., Iwasaki T., Endo K., Mohri S., Shimizu J., Yada T., Ogasawara Y., Naruse K., Ohe T., Kajiya F. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats. Am. J. Physiol. 2007, 292:H2737-H2744.
84. Kappert K., Schmidt G., Doerr G., Wollert-Wulf B., Fleck E., Graf K. Angiotensin II and PDGF-BB stimulate - integrin mediated adhesion and spreading in human SMCs. Hypertension 2000, 35:255-261.
85. Kedziora-Kornatowska K., Szram S., Kornatowski T., Szadujkis-Szadurski L., Kedziora J., Bartosz G. bEffect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron. Exp. Nephrol. 2003, 95:e134-e143.
86. Kehrer J.P. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000, 149:43-50.
87. Kim S.S., Gallaher D.D., Csallany A.S. Vitamin E and probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocin-induced diabetic rats. Lipids 2000, 35:1225-1237.
88. Kimura S., Zhang G.X., Nishiyama A., Shokoji T., Yao L., Fan Y.Y., Rahman M., Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005, 45:438-444.
89. Kowluru R.A., Abbas S.N., Odenbach S. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J. Diabetes Complications 2004, 18:282-288.
90. Koya D., Lee I.K., Ishii H., Kanoh H., King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 1997, 8:426-435.
91. Kuhad A., Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci. 2009, 84:296-301.
92. Kuwano Y., Tominaga K., Kawahara T., Sasaki H., Takeo K., Nishida K., Masuda K., Kawai T., Teshima-Kondo S., Rokutan K. Tumor necrosis factor alpha activates transcription of the NADPH oxidase organizer 1 (NOXO1) gene and upregulates superoxide production in colon epithelial cells. Free Radic. Biol. Med. 2008, 45:1642-1652.
93. Lamb D.J., Wilkins G.M., Leake D.S. The oxidative modification of low density lipoprotein by human lymphocytes. Atherosclerosis 1992, 92:187-192.
94. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003, 111:1201-1209.
95. Langenstroer P., Pieper G.M. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. 1992, 263:H257-H262.
96. Lee E.Y., Chung C.H., Kim J.H., Joung H.J., Hong S.Y. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes. Nephrol. Dial. Transplant. 2006, 21:1496-1503.
97. Lekakis J., Papamichael C., Anastasiou H., Alevizaki M., Desses N., Souvatzoglou A., Stamatelopoulos S., Koutras D.A. Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc. Res. 1997, 34:164-168.
98. Li H., Forstermann U. Resveratrol, a multifunctional compound improving endothelial function. Cardiovas. Drugs. Ther. 2009, 23:425-429.
99. Li L., Renier G. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metabolism 2006, 55:1516-1523.
100. Li J.M., Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: role of the p47 phox subunit. J. Biol. Chem. 2003, 278:12094-12100.
101. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. 2004, 287:R1014-R1030.
102. Li X.N., Song J., Zhang L., LeMaire S.A., Hou X., Zhang C., Coselli J.S., Chen L., Wang X.L., Zhang Y., Shen Y.H. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 2009, 58:2246-2257.
103. Lin L., Park S., Lakatta E.G. RAGE signaling in inflammation and arterial aging. Front. Biosci. 2009, 1:1403-1413.
104. Linder N., Rapola J., Raivio K.O. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab. Invest. 1999, 79:967-974.
105. Liochev S.I. The mechanism of 'Fenton-like' reactions and their importance for biological systems. A biologist's view. Metal. Ions. Biol. Syst. 1999, 36:1-39.
106. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., Dagenais G.R. Effcet of long-term vitamin E supplementation on cardiovascular events and cancer: a randomised, controlled trial. JAMA 2005, 293:1338-1347.
107. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 1993, 268:1908-1913.
108. Makino A., Ohuchi K., Kamata K. Mechanisms underlying the attenuation of endothelium-dependent vasodilation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br. J. Pharmacol. 2000, 130:549-566.
109. Mayer B., John M., Bohme E. Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS. Lett. 1990, 277:215-219.
110. Mayhan W.G. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 1989, 256:H621-H625.
111. McIntyre M., Bohr D.F., Dominiczak A.F. Endothelial function in hypertension, the role of superoxide anion. Hypertension 1999, 34:539-545.
112. Mekinova D., Chorvathova V., Volkovova K., Staruchova M., Grancicova E., Klvanoca J., Ondreicka R. Effect of intake of exogenous vitamins C, E and beta-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995, 39:257-261.
113. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. High dose vitamin E may increase all cause-mortality. Ann. Intern. Med. 2005, 142:37-46.
114. Milstien S., Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Communic. 1999, 263:681-684.
115. Miwa S., St-Pierre J., Partridge L., Brand M.D. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic. Biol. Med. 2003, 35:938-948.
116. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995, 9:1319-1330.
117. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
118. Morcos M., Borcea V., Isermann B., Gehrke S., Ehret T., Henkels M., Schiekofer S., Hofmann M., Amiral J., Tristschler H., Ziegler R., Wahl P., Nawroth P.P. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res. Clin. Pract. 2001, 52:175-183.
119. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984, 4:357-364.
120. Morrison J., Knoll K., Hessner M.J., Liang M. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol. Genomics. 2004, 17:271-282.
121. Mueller C.F., Laude K., McNally J.S., Harrison D.G. ATVB in focus: redox mechanisms in blood vessels. Arterioscler. Thromb. Vasc. Biol. 2005, 25:274-278.
122. Muller F. The nature and mechanism of superoxide production by the electron transport chain. J. Am. Aging Assoc. 2000, 23:227-253.
123. Münzel T., Sinning C., Post F., Warnholtz A., Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann. Med. 2008, 40:180-196.
124. Nakhoul F.M., Miller-Lotan R., Awad H., Asleh R., Jad K., Nakhoul N., Asaf R., Abu-Saleh N., Levy A.P. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am. J. Physiol. 2009, 296:F830-F838.
125. Nassar T., Kadery B., Lotan C., Da'as N., Kleinman Y., Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2002, 436:111-118.
126. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
127. Neri S., Signorelli S.S., Torrisi B., Pulvirenti D., Mauceri B., Abate G., Ignaccolo L., Bordonaro F., Cilio D., Calvagno S., Leotta C. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clin. Ther. 2005, 27:1764-1773.
128. Nieto N., Friedman S.L., Greenwel P., Cederbaum A. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 2001, 30:987-996.
129. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
130. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999, 274:21645-21650.
131. Node K., Huo Y., Ruan X., Baichun Y., Spiecker M., Ley K., Zeldin D.C., Liao J.K. Antiinflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285:1276-1279.
132. s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J. Biol. Chem. 2001, 276:15983-15989.
133. Ohshiro Y., Ma R.C., Yasuda Y., Hiraoka-Yamamoto J., Clermont A.C., Isshiki K., Yagi K., Arikawa E., Kern T.S., King G.L. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 2006, 55:3112-3120.
134. Oleinick N.L., Evans H.H. Poly (ADP-ribose) and the response of cells to ionizing radiation. Radiat. Res. 1985, 101:29-46.
135. Orlova V.V., Choi E.Y., Xie C., Chavakis E., Bierhaus A., Ihanus E., Ballantyne C.M., Gahmberg C.G., Bianchi M.E., Nawroth P.P., Chavakis T. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 2007, 26:1129-1139.
136. Pacher P., Szabo C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid. Redox. Signal. 2005, 7:1568-1580.
137. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
138. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14483-14488.
139. Palmer R.M., Rees D.D., Ashton D.S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophy. Res. Commun. 1988, 153:1251-1256.
140. Pannirselvam M., Ding H., Anderson T.J., Triggle C.R. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 2006, 551:98-107.
141. Parihar M.S., Brewer G.J. Mitoenergetic failure in Alzheimer disease. Am. J. Physiol. 2007, 292:C8-C23.
142. Parthasarathy S., Printz D.J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986, 6:505-510.
143. Parthiban A., Vijayalingam S., Shanmugasundaram K.R., Mohan R. Oxidative stress and the development of diabetic complications-antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell. Biol. Int. 1995, 19:987-993.
144. Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., Zhang C. Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 2006, 99:69-77.
145. Pieper G.M., Langenstroer P., Siebenich W. Diabetic-induced endothelial dysfunction in rat aorta: roe of hydroxyl radicals. Cardiovasc. Res. 1997, 34:145-156.
146. Pieper A.A., Verma A., Zhang J., Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends. Pharmacol. Sci. 1999, 20:171-181.
147. Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10480-10484.
148. Puntarulo S., Cederbaum A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free. Radical. Biol. Med. 1998, 24:1324-1330.
149. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Motz E., Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NADPH-oxidase activation. Diabetes 2003, 52:2795-2804.
150. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends. Biochem. Sci. 2000, 25:502-508.
151. Ray R., Shah A.M. NADPH oxidase and endothelial cell function. Clin. Sci. 2005, 109:217-226.
152. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., Stumvoll M., Kahn C.R., Blüher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8665-8670.
153. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
154. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 1986, 250:H822-H827.
155. Sartoretto J.L., Oliveira M.A., Nigro D., Carvaho M.H.C., Tostes R.C., Fortes Z.B. Constrictor responses to noradrenaline, hemodynamic profile, and superoxide levels measured by hydroethidine oxidation in diabetic rats. Biol. Pharm. Bull. 2007, 1938-1942.
156. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond). 2005, 109:143-159.
157. Schulze P.C., Yoshioka J., Takahashi T., He Z., King G.L., Lee R.T. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 2004, 279:30369-30374.
158. Shimokawa H., Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol. Res. 2004, 49:543-549.
159. Szabo C., Zanchi A., Komjati K., Pacher P., Krolewski A.S., Quist W.C., LoGerfo F.W., Horton E.S., Veves A. Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002, 106:2680-2686.
160. Szabo C., Biser A., Benko R., Böttinger E., Suszták K. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 2006, 55:3004-3012.
161. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 1992, 263:321-326.
162. Thallas-Bonke V., Thorpe S.R., Coughlan M.T., Fukami K., Yap F.Y., Sourris K.C., Penfold S.A., Bach L.A., Cooper M.E., Forbes J.M. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008, 57:460-469.
163. Thomas C., Mackey M.M., Diaz A.A., Cox D.P. Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox. Rep. 2009, 14:102-108.
164. Touyz R.M., Tabet F., Schiffrin E.L. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin. Exp. Pharmacol. Physiol. 2003, 30:860-866.
165. Trushina E., McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007, 145:1233-1248.
166. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
167. Ujihara N., Sakka Y., Takeda M., Hirayama M., Ishii A., Tomonaga O., Babazono T., Takahashi C., Yamashita K., Iwamoto Y. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Diabetes Res. Clin. Prac. 2002, 58:109-114.
168. Vega-Lopez S., Devaraj S., Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J. Invest. Med. 2004, 52:24-32.
169. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
170. Watts G.F., O'Brien S.F., Silvester W., Millar J.A. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin. Sci. (Lond) 1996, 91:567-573.
171. 2-dependent form (type O). Arch. Biochem. Biophys. 1976, 172:365-379.
172. Whiting P.H., Kalansooriya A., Holbrook I., Haddad F., Jennings P.E. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br. J. Biomed. Sci. 2008, 65:71-74.
173. Winterbone M.S., Sampson M.J., Saha S., Hughes J.C., Hughes D.A. Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test-a randomised controlled trial. Cardiovasc. Diabetol. 2007, 6:8.
174. Wong W.T., Tian X., Xu A., Ng C.F., Lee H.K., Chen Z.Y., Au C.L., Yao X., Huang Y. Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. Antioxid. Redox. Signal. 2010, Electronic publication ahead of print.
175. Woodman O.L., Malakul W., Cao A.H., Xu Q., Ritchie R.H. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction. Life Sci. 2008, 82:847-854.
176. Wright E., Scism-Bacon J.L., Glass L.C. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract. 2006, 60:308-314.
177. Xia L., Wang H., Munk S., Kwan J., Goldberg H.J., Fantus I.G., Whiteside C.I. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am. J. Physiol. 2008, 295:F1705-F1714.
178. Xu B., Chiu J., Feng B., Chen S., Chakrabarti S. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Diabetes Metab. Res. Rev. 2008, 24:404-412.
179. Xue M., Qian Q., Adaikalakoteswari A., Rabbani N., Babaei-Jadidi R., Thornalley P.J. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008, 57:2809-2817.
180. Yang B., Graham L., Dikalov S., Mason R.P., Falck J.R., Liao J.K., Zeldin D.C. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia reoxygenation injury in cultured bovine aortic endothelial cells. Mol. Pharmacol. 2001, 60:310-320.
181. Yang S., Madyastha P., Bingel S., Ries W., Key L. A new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 2001, 276:5452-5458.
182. Yao D., Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010, 59:249-255.
183. Yeop Han C., Kargi A.Y., Omer M., Chan C.K., Wabitsch M., O'Brien K.D., Wight T.N., Chait A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010, 59:386-396.
184. Yorek M.A., Dunlap J.A. Effects of increased concentration of D-glucose or L-fucose on monocyte adhesion to endothelial cell monolayers and activation nuclear factor kB. Metabolism 2002, 51:225-234.
185. Yoshida Y., Saito Y., Jones L.S., Shigeri Y. Chemical reactivities and physical effects in comparison between tocopherols and tocotrienols: physiological significance and prospects as antioxidants. J. Biosci. Bioeng. 2007, 104:439-445.
186. Yoshioka J., Schreiter E.R., Lee R.T. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid. Redox. Signal. 2006, 8:2143-2151.
187. Young C.N., Koepke J.I., Terlecky L.J., Borkin M.S., Boyd Savoy L., Terlecky S.R. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J. Invest. Dermatol. 2008, 128:2606-2614.
188. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000, 342:154-160.
189. Zalba G., San Jose G., Moreno M.U., Fortuño M.A., Fortuño A., Beaumont F.J., Díez J. Oxidative stress in arterial hypertension: role of NADPH oxidase. Hypertens 2001, 38:1395-1399.
190. Zalba G., San Jose G., Moreno M.U., Fortuno A., Diez J. NADPH oxidase-mediated oxidative stress: genetic studies of the p22 (phox) gene in hypertension. Antioxid. Redox. Signal. 2005, 7:1327-1336.
191. Zhang P., Hou M., Li Y., Xu X., Barsoum M., Chen Y.J., Bache R.J. NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart. Am J. Physiol. 2009, 296:H840-H846.
192. Zhang H., Zhang J., Ungvari Z., Zhang C. Resveratrol improves endothelial function: role of TNFα and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1164-1171.
193. Zheng S., Carlson E.C., Yang L., Kralik P.M., Huang Y., Epstein P.N. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19:2077-2085.